The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival

Nephrology Dialysis Transplantation

Volumn 28, Issue 5, 2013, Pages 1305-1314

  Moroni, Gabriella ^a   Longhi, Selena ^a   Quaglini, Silvana ^a,b   Gallelli, Beniamina ^a   Banfi, Giovanni ^a   Montagnino, Giuseppe ^a   Messa, Piergiorgio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

IgA nephropathy; recurrent glomerulonephritis; renal transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME;

IGA NEPHROPATHY; RECURRENT GLOMERULONEPHRITIS; RENAL TRANSPLANTATION;

ADULT; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84877939202     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs472     Document Type: Article

References (35)

1. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988; 12: 340-347
2. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-727
3. Kim YS, Moon JI, Jeong HJ et al. Live donor renal allograft in end-stage renal failure patients from immunoglobulin A nephro-pathy. Transplantation 2001; 71: 233-238
4. Andresdottir MB, Hoitsma AJ, Assmann KJ et al. Favorable outcome of renal transplantation in patients with IgA nephropa-thy. Clin Nephrol 2001; 56: 279-288
5. Chacko B, George JT, Neelakantan N et al. Outcomes of renal transplantation in patients with immunoglobulin A nephropathy in India. J Postgrad Med 2007; 53: 92-95
6. Ponticelli C, Traversi L, Feliciani A et al. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 2001; 60: 1948-1954
7. Choy BY, Chan TM, Lo SK et al. Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 2003; 18: 2399-2404
8. Andresdottir MB, Haasnoot GW, Doxiadis II et al. Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: a retrospective analysis of registry data. Transplantation 2005; 80: 1012-1018
9. Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 2010; 5: 2363-2372
10. Hariharan S, Adams MB, Brennan DC et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999; 68: 635-641
11. Briganti EM, Russ GR, McNeil JJ et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 347: 103-109
12. Berger J, Noël LH, Nabarra B. Recurrence of mesangial IgA ne-phropathy after renal transplantation. Contrib Nephrol 1984; 40: 195-197
13. Bachman U, Biava C, Amend W et al. The clinical course of IgA-nephropathy and Henoch-Schönlein purpura following renal transplantation. Transplantation 1986; 42: 511-515
14. Hartung R, Livingston B, Excell L et al. Recurrence of IgA deposits/disease in grafts. An Australian Registry Survey 1980-1990. Contrib Nephrol 1995; 111: 13-27
15. Kessler M, Hiesse C, Hestin D et al. Recurrence of immunoglobu-lin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis 1996; 28: 99-104
16. Frohnert PP, Donadio JV, Jr, Velosa JA et al. The fate of renal transplants in patients with IgA nephropathy. Clin Transplant 1997; 11: 127-133
17. Ohmacht C, Kliem V, Burg M et al. Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss. Transplantation 1997; 64: 1493-1496
18. Bumgardner GL, Amend WC, Ascher NL et al. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 1998; 65: 1053-1060
19. Freese P, Svalander C, Nordén G et al. Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant 1999; 13: 313-317
20. Wang AY, Lai FM, Yu AW et al. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 2001; 38: 588-596
21. Chandrakantan A, Ratanapanichkich P, Said M et al. Recurrent IgA nephropathy after renal transplantation despite immunosup-pressive regimens with mycophenolate mofetil. Nephrol Dial Transplant 2005; 20: 1214-1221
22. Berthoux F, El Deeb S, Mariat C et al. Antithymocyte globulin (ATG) induction therapy and disease recurrence in renal transplant recipients with primary IgA nephropathy. Transplantation 2008; 85: 1505-1507
23. Han SS, Huh W, Park SK et al. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy. Transpl Int 2010; 23: 169-175
24. McDonald SP, Russ GR. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation 2006; 82: 759-762
25. Working Group of the International IgA Nephropathy Network and the Renal Pathology SocietyRoberts IS, Cook HT, Troyanov S et al. The Oxford classification of IgA ne-phropathy: pathology definitions, correlations, and reproduci-bility. Kidney Int 2009; 76: 546-556
26. Solez K, Colvin RB, Racusen LC et al. Differential diagnosis of chronic allograft injury and elimination of chronic allograft ne-phropathy (CAN). Am J Transplant 2007; 7: 518-526
27. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154
28. Lim EC, Terasaki PI. Outcome of renal transplantation in different primary diseases. Clin Transpl 1991; 293-303
29. Odum J, Peh CA, Clarkson AR et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994; 9: 309-312
30. Chailimpamontree W, Dmitrienko S, Li G et al. Genome Canada Genome Canada biomarkers in transplantation group. Probability, predictors, and prognosis of posttransplantation glomeru-lonephritis. J Am Soc Nephrol 2009; 20: 843-851
31. Benabdallah L, Rerolle JP, Peraldi MN et al. An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy. Am J Kidney Dis 2002; 40: E20
32. Jeong HJ, Kim YS, Kwon KH et al. Glomerular crescents are responsible for chronic graft dysfunction in post-transplant IgA nephropathy. Pathol Int 2004; 54: 837-842
33. Mulay AV, van Walraven C, Knoll GA. Impact of immuno-suppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant 2009; 9: 804-811
34. Clayton P, McDonald S, Chadban S. Steroids and recurrent IgA nephropathy after kidney transplantation. Am J Transplant 2011; 11: 1645-1649
35. Oka K, Imai E, Moriyama T et al. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial transplant 2000; 15: 689-695